HBM Holdings closed at HK$15.08 after the market had a full day to process its half year numbers. The stock has cooled over the past week but is still up strongly over the past month, which matters when you look at what these results actually say. The headline is not revenue or earnings per share; the story is margin pressure, with trailing net profit margin at 47.2% compared with 63.1% a year ago, while the stock trades on a P/E of 19.8x and above a discounted cash flow value of HK$8.96.
Like the high headline margin at HBM Holdings but uneasy about the pressure on profitability and the share price sitting above its discounted cash flow estimate? Take a look at our curated list of resilient, cash generative companies in the 302 resilient stocks with low risk scores.
Prefer visual charts instead of scrolling through another wall of earnings figures and margin commentary for HBM Holdings? Get a clear, visual view of the company’s valuation picture in the company report for HBM Holdings.
For investors attracted to HBM Holdings for its platform and partnership story, the latest half year numbers broadly line up with that angle. Revenue reached US$122.491 million compared with US$101.315 million a year earlier, which fits with progress at Nona Biosciences and a busier licensing and collaboration slate. Seven consecutive profitable half years and confirmation of a profit alert also back the idea that the business model is converting science and partnerships into cash, even if margin pressure means earnings are not keeping pace with revenue for now.
The cautious view on HBM Holdings also finds support in these results. Net income fell to US$64.879 million from US$71.718 million despite higher revenue, and basic EPS moved from US$0.093077 to US$0.08. Trailing net profit margin of 47.2% compared with 63.1% a year ago points to rising cost intensity as the pipeline and collaborations scale. The 7 day share price decline of 5.16% after a strong 30 and 90 day run suggests the market is already questioning how sustainable the current profitability profile really is.
Compare the revenue momentum and margin pressure at HBM Holdings with what the street is signaling on future upside or downside. See the consensus price target analysis for HBM Holdings to check whether analyst targets line up with the current HK$15.08 share price or point in a different direction.If the mix of revenue momentum and margin pressure at HBM Holdings has your attention, register free with Simply Wall St and add it to a Watchlist to track the share price against fair value and watch for a more comfortable entry point. Once you are invested, use the Portfolio Command Center to keep an eye on earnings, valuation updates and key announcements without getting buried in day to day noise. For a longer term perspective, the Community helps you compare your thesis on HBM Holdings with thousands of other investor views and questions. By spotting potential catalysts and risks early, you give yourself a better chance to stay ahead of the market rather than reacting after the fact.
Fresh stock ideas can move from quiet to flying once momentum builds. Use these under the radar for now picks before the early edge drops away and get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com